An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Clinical trial NCT05732402 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05732402
Sponsor: Alpine Immune Sciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis Immunoglobulin A Nephropathy Membranous Nephropathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Start date: 2023-03-15
Primary completion: 2028-03-02
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.